These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1063031)

  • 1. Manipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia.
    Lampkin BC; McWilliams NB; Mauer AM; Flessa HC; Hake DA; Fisher V
    Br J Haematol; 1976 Jan; 32(1):29-40. PubMed ID: 1063031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission induction in acute myelogenous leukemia using cytosine arabinoside synchronization: a Southwest Oncology Group Study.
    Steuber CP; Humphrey GB; McMillan CW; Vietti TJ
    Med Pediatr Oncol; 1978; 4(4):337-42. PubMed ID: 281596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Adriamycin in acute leukaemia.
    Smith IE; McElwain TJ
    Lancet; 1974 Jul; 2(7873):161. PubMed ID: 4135524
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
    Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961
    [No Abstract]   [Full Text] [Related]  

  • 6. Adriamycin in the treatment of acute leukaemia.
    Whitehouse JM; Crowther D; Bateman CJ; Beard ME; Malpas JS
    Br Med J; 1972 Feb; 1(5798):482-3. PubMed ID: 4500405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.
    Bär BM; de Witte T; de Pauw BE; Haanen C
    Neth J Med; 1990 Feb; 36(1-2):19-24. PubMed ID: 2314517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult acute leukaemia.
    Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
    Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.
    Yates J; Glidewell O; Wiernik P; Cooper MR; Steinberg D; Dosik H; Levy R; Hoagland C; Henry P; Gottlieb A; Cornell C; Berenberg J; Hutchison JL; Raich P; Nissen N; Ellison RR; Frelick R; James GW; Falkson G; Silver RT; Haurani F; Green M; Henderson E; Leone L; Holland JF
    Blood; 1982 Aug; 60(2):454-62. PubMed ID: 6953986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults.
    Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K
    Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute myeloid leukaemia with cytosine arabinoside and daunomycin in combination.
    Brincker H
    Scand J Haematol; 1972; 9(6):657-64. PubMed ID: 4509284
    [No Abstract]   [Full Text] [Related]  

  • 14. Synchronization and recruitment in acute leukemia.
    Lampkin BC; Nagao T; Mauer AM
    J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High remission-induction rate in acute myeloid leukaemia.
    Gale RP; Cline MJ
    Lancet; 1977 Mar; 1(8010):497-9. PubMed ID: 65605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.
    Schiller G; Gajewski J; Nimer S; Territo M; Ho W; Lee M; Champlin R
    Br J Haematol; 1992 Jun; 81(2):170-7. PubMed ID: 1643014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of acute myeliod leukaemia.
    Friend JH; Giles C; Richardson SG
    J Clin Pathol; 1974 Jan; 27(1):53-4. PubMed ID: 4522738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years].
    Creutzig U; Ritter J; Langermann HJ; Riehm H; Henze G; Niethammer D; Jürgens H; Stollmann B; Lasson U; Kabisch H; Wahlen W; Löffler H; Schellong G
    Klin Padiatr; 1983; 195(3):152-60. PubMed ID: 6576202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.